Swissfinity Group

Biotechnology Research • • 1-10 Employees

Company overview

Headquarters	XX
Website	swissfinity-group.com
NAICS	541714
Employees	1-10

Key Contact at Swissfinity Group

Chris Barkey

CEO

Swissfinity Group Email Formats

Swissfinity Group uses 1 email format. The most common is {first name} (e.g., john@swissfinity-group.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@swissfinity-group.com	100%

About Swissfinity Group

Swissfinity is a European investment group, dedicated to the advanced biotech sector, specializing in the field of cell and gene therapy and enabling technologies. Beyond providing capital, we offer strategic advisory and consultancy services to our portfolio and partner companies. Our team comprises seasoned professionals with over 150 years of combined interdisciplinary excellence. We leverage our business experience and global network to build strong investment portfolios and to provide tailored solutions in consulting for: • M&A processes, • management transition and restructuring, • as well as business development and market strategy. At Swissfinity Group we support the cure. Our mission is to empower companies with great ideas to further drive life sciences and healthcare innovation.

Swissfinity Group revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	No funding